Google DeepMind 推出 Co-Scientist：加速肝臟疾病機制研究與個人化藥物開發
Original: Accelerating discovery of liver disease mechanisms
This latest case study from Google DeepMind details how AI is playing a pivotal role in the biomedical field. Professor Filippo Menolascina…
Google DeepMind 分享了研究員 Filippo Menolascina 如何利用 AI 系統「Co-Scientist」來攻克複雜的肝臟疾病。該系統不僅協助識別出全新的肝臟疾病治療方案，還成功解釋了為何現有藥物只對部分患者群體產生療效。這項突破展示了 AI 代理（AI Agents）在生物醫學與精準醫療領域的巨大潛力，能大幅縮短科學假說的驗證週期。
This latest case study from Google DeepMind details how AI is playing a pivotal role in the biomedical field. Professor Filippo Menolascina of the University of Edinburgh has successfully leveraged DeepMind's AI system "Co-Scientist" to accelerate the exploration of liver disease mechanisms and the development of new drugs.
Free shows the 3-line summary; Pro unlocks the full deep summary (~300 words) so you never have to click through.
See Pro plans →Want the original English / full article?
Read on Google DeepMind Blog →Summaries are AI-generated; the original article is authoritative.